|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
|Click here to place your 2015 Proficiency Testing order or to view your previous Performance and Summary reports.
|Access to educational information is free to ASHI members. CECs are awarded through an online testing process and are free to ASHI members.
ABHI application deadline June 1, 2015!
ABHI is accepting applications for the certification examinations: CHA, CHS, CHT, and Laboratory Director for the September administration. The application deadline is June 1. Apply now.
Visit WWW.ASHI-HLA.ORG/ABHI for instructions and an application.
| Share this article:
Rose Payne and Outstanding Technologist Award nominations
There are only two weeks left to submit your nominations for the Rose Payne and Outstanding Technologist Award! The Rose Payne Award recognizes distinguished scientific accomplishment and extraordinary contributions to the immunogenetics community. Specifically, this award recognizes contributions to the advancement of histocompatibility and immunogenetics and other extraordinary contributions. Do you know an outstanding technologist who should be recognized for his/her efforts? The Outstanding Technologist Award is presented annually to a technologist who has provided outstanding contributions to the field of histocompatibility and immunogenetics.
|ROSE PAYNE AWARD
ASHI membership is not required
|*Distinguished scientific accomplishments in the field of histocompatibility and immunogenetics
* Contributions to the advancement of histocompatibility and immunogenetics
*Other extraordinary contributions (please explain)
|*Letter of nomination
*Two additional supporting letters (only one required if nominator is an ASHI member)
*Candidate's biosketch and curriculum vitae
|OUTSTANDING TECHNOLOGIST AWARD
ASHI membership (non-doctoral) is required.
|*Contributions to advancement of technology and science of HLA immunogenetics
*Service to ASHI or ABHI as a committee member, director, officer, etc.
*Educational contributions on behalf of ASHI at a regional or national level
* Certification in histocompatibility
* Other extraordinary contributions (please explain)
|*Letter of nomination from an ASHI member
*Two additional supporting letters
*Candidate's curriculum vitae
*Cannot have previously received the award
Click here for a listing of past awardees.
Submit your nominations now!
NOMINATIONS FOR ALL AWARDS MUST BE RECEIVED BY JUNE 1, 2015.
Send nominations and supporting information to:
ASHI Executive Office
ASHI Technologists Survey
Have you taken ASHI's Technologist Survey yet?
The ASHI Technologist Affairs Committee is conducting a survey of all HLA technologists in North America. This survey is completely anonymous and consists of general questions from location and gender to more specific questions like salary information and compensation for on-call pay. Please take time to thoughtfully answer each question and feel free to add any comments or other information at the end of the survey. Our goal is for each North American HLA technologist to have the opportunity to take this survey so if someone in your lab did not receive the email link please forward the email to them. Once the survey results are tabulated, the summary will be made available on the ASHI website inside the member's only section.
The ASHI Technologist Affairs Committee wants to thank you in advance for your participation in this important survey!!
MISSED AN ISSUE OF ASHI INSIGHTS? |
Click here to visit the ASHI Insights archive page.
2015 Membership Directory
The 2015 Membership Directory PDF version is available upon request at firstname.lastname@example.org to members only.
The online version with the most up to date information can be found in the Members Only section of the website.
Philadelphia Regional Education Workshop — June 18-20, 2015
Register and reserve your room today to secure your spot!
Mexico City Workshop
34th current course on immunogenetics and 30th current course on molecular genetics — didactic and laboratory parts
The workshop will be presented part in Spanish and part in English. The invited speakers from abroad will present their lectures in English. Continuing Education Credits will be provided by the American Board of Histocompatibility and Immunogenetics (ABHI) for attendance at this workshop, with the Academic accreditation of The Faculty of Medicine, UNAM (Universidad Nacional Autonoma de Mexico).
It is accepted as an optional subject for Ph.D. programs in Mexican Latinamerican and Spanish Universities.
2015 Joint BANFF-CST Scientific Meeting abstract deadline — EXTENDED TO MAY 25!
The Canadian Society of Transplantation and The Banff Foundation of Allograft Pathology are pleased to co-host the 2015 Banff-CST Joint Scientific Meeting to be held in Vancouver, BC from October 5 to 10, 2015. This meeting is a first of its kind in bringing together the international transplantation community, including clinicians, pathologists, immunogeneticists, basic scientists, allied health care colleagues, and policy makers. We anticipate an overall attendance of 600 participants during the meeting and look forward to seeing you in October! More information about the meeting may be found at: http://www.cst-transplant.ca/meetings_asm.html
The dilemma of DQ HLA-antibodies
Accurate identification of antibody reactivity against HLA-DQ antigens was difficult by using the old serological assays because of the strong linkage disequilibrium between HLA-DR and HLA-DQ (the usual inheritance of a certain HLA-DR molecule that ties together with the same DQ molecule within a racial group). The accurate and precise identifications of anti-HLA-antibodies of DQ specificities were made possible with the introduction of multiplex-bead arrays (Luminex), using single antigen bead (SAB) assay. The SAB assay is also considered today to be the most sensitive and specific method for alloimmunization assessment even for the low titer anti-HLA-antibodies.
HLA-matched transplantation improves OS in high-risk MDS
HLA-matched allogeneic hematopoietic stem cell transplantation (HSCT) was associated with more than a doubling in 4-year overall survival (OS) rates for patients with intermediate-2 or high-risk myelodysplastic syndromes (MDS), according to findings presented at the 2015 International MDS Symposium.
Autoimmune or autoiflammatory? Bad to the bone
Inflammatory arthritis is a joint disease characterized by leukocyte invasion and synoviocyte activation followed by cartilage and bone destruction. There are multiple types of inflammatory arthritis including the most common, juvenile idiopathic arthritis (JIA), rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS). Variable etiologies contribute to the pathogenesis of these diseases, and at large, remain poorly understood.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063